SEC Form 4 · accession 0001209191-19-018614
Neuronetics, Inc. · STIM
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Yelena Tropsha
Officer — VP of Commercial Access
Period of report
Mar 8, 2019
Accepted (ET)
Mar 11, 2019 · 7:15 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001227636
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1,F2 | Mar 8, 2019 | A | 9,135 | — | A | 9,135 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Employee Stock Option (right to buy)F3 | $16.42 | Mar 8, 2019 | A | 16,077 | A | — | Mar 8, 2029 | Common Stock | 16,077 | 16,077 | D |
Explanation of responses
- F1Twenty-five percent (25%) of the shares subject to the restricted stock unit ("RSU") grant shall vest on each of March 8, 2020 and March 8, 2021, and fifty percent (50%) of the shares subject to the RSU grant shall vest on March 8, 2022, subject to Reporting Person continuing to provide service through each such date.
- F2Each RSU represents a contingent right to receive one share of the Issuer's common stock.
- F3Twenty-five percent (25%) of the shares subject to the option shall vest on March 8, 2020, and one thirty-sixth (1/36th) of the remaining shares subject to the option shall vest each month thereafter, subject to Reporting Person continuing to provide service through each such date.